netFormulary NHS
North Central London
Joint Formulary
 Search
 Formulary Chapter 3: Respiratory system - Full Chapter
Chapter Links...
 Details...
03.12  Expand sub section  Other respiratory medicines
Methotrexate tablets
(Severe asthma)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted

NOTE: There is more than one monograph for Methotrexate, click here to search for formulary status and its use for other indications. 

Approved for severe asthma. Restricted to the Severe Asthma Service  (September 2015)

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
   
Methotrexate tablets
(Sarcoidosis)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
GP - Amber

NOTE: There is more than one monograph for Methotrexate, click here to search for formulary status and its use for other indications. 

Approved for sarcoidosis after failure of steroids  (JFC April 2016)

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Restricted to the Sarcoid Clinic
    • Only 2.5mg tablets to be prescribed
    • See pharmacy policy for the safe dispensing of methotrexate
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • See indication above
 
Link   NCL JFC: Shared care Guideline - Prescribing and Monitoring of oral methotrexate for licensed and off-label indications
   
Mycophenolate mofetil
(Interstitial lung diseases)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Approved for Interstitial lung disease (Connective tissue disease, Hypersensitivity Pneumonitis and Idiopathic Non-specific Interstitial Pneumonia) (JFC April 2016).

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • As per above agreed indications
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
   
 ....
 Non Formulary Items
Aspirin lysine intranasal

View adult BNF View SPC online View childrens BNF
Non Formulary
Black

Not approved for the management of NSAID exacerbated respiratory disease (JFC October 2019)

 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

GP - 1st

Medicines suitable for first-line use within primary care.

Can be initiated within primary care within their licensed indication, in accordance with nationally recognised formularies, for example the BNF, BNF for Children, Medicines for Children or Palliative Care Formulary. Primary care prescribers take full responsibility for prescribing. 

  

GP - 2nd

Medicines suitable for second-line use within primary care.

Can be initiated within primary care within their licensed indication, in accordance with nationally recognised formularies, for example the BNF, BNF for Children, Medicines for Children or Palliative Care Formulary. Primary care prescribers take full responsibility for prescribing. 

  

GP - Amber

Medicines that should be initiated by a specialist. Prescribing can be transferred to primary care once the patient has been stabilised.  

Shared care: For drugs with regular, ongoing need for monitoring and/or assessment of efficacy or toxicity. Prior agreement must be obtained by the specialist from the primary care provider before prescribing responsibility is transferred. The shared care protocol must have been agreed by the relevant secondary care trust Drugs and Therapeutics Committee(s) (DTC) and approved by the North Central London JFC.

Fact sheet: For drugs with some concerns surrounding safety or efficacy but do not require regular monitoring and/or monitoring of effectiveness/toxicity.

  

GP - Red

Medicines which should normally be prescribed by specialists only (hospital only).

For patients already receiving prescriptions in primary care - continue. No new patients to receive prescriptions in primary care.

  

GP - Grey

Medicines on hospital formularies which have not been reviewed for suitability in primary care.  

Black

Medicines not recommended for routine use in primary or secondary care.

Medicines, which the North Central London JFC has actively reviewed and does not recommend for use at present due to limited clinical and/or cost effective data.

  

netFormulary